Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Recent advances and results from the solid radiochemistry nuclear diagnostic at the National Ignition Facility.

Gharibyan N, Shaughnessy DA, Moody KJ, Grant PM, Despotopulos JD, Faye SA, Jedlovec DR, Yeamans CB.

Rev Sci Instrum. 2016 Nov;87(11):11D813.

PMID:
27910632
2.

From neurocognition to community participation in serious mental illness: the intermediary role of dysfunctional attitudes and motivation.

Thomas EC, Luther L, Zullo L, Beck AT, Grant PM.

Psychol Med. 2017 Apr;47(5):822-836. doi: 10.1017/S0033291716003019. Epub 2016 Nov 25.

PMID:
27884217
3.

A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.

Collins SE, Grant PM, Uwinkindi F, Talbot A, Seruyange E, Slamowitz D, Mugeni A, Remera E, Niyonsenga SP, Nyirimigabo J, Uwizihiwe JP, Dongier P, Muhayimpundu R, Mazarati JB, Zolopa A, Nsanzimana S.

Open Forum Infect Dis. 2016 Jul 1;3(3):ofw141. eCollection 2016 Sep.

4.

Long-term body composition changes in antiretroviral-treated HIV-infected individuals.

Grant PM, Kitch D, McComsey GA, Collier AC, Bartali B, Koletar SL, Erlandson KM, Lake JE, Yin MT, Melbourne K, Ha B, Brown TT.

AIDS. 2016 Nov 28;30(18):2805-2813.

PMID:
27662545
5.

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.

Grant PM, Kitch D, McComsey GA, Collier AC, Koletar SL, Erlandson KM, Yin MT, Bartali B, Ha B, Melbourne K, Brown TT.

J Infect Dis. 2016 Aug 15;214(4):607-11. doi: 10.1093/infdis/jiw204. Epub 2016 Jun 20.

PMID:
27330053
6.

Tenofovir and bone health.

Grant PM, Cotter AG.

Curr Opin HIV AIDS. 2016 May;11(3):326-32. doi: 10.1097/COH.0000000000000248. Review.

7.

Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.

Collins SE, Grant PM, Shafer RW.

Drugs. 2016 Jan;76(1):75-98. doi: 10.1007/s40265-015-0515-6. Review.

8.

Note: Radiochemical measurement of fuel and ablator areal densities in cryogenic implosions at the National Ignition Facility.

Hagmann C, Shaughnessy DA, Moody KJ, Grant PM, Gharibyan N, Gostic JM, Wooddy PT, Torretto PC, Bandong BB, Bionta R, Cerjan CJ, Bernstein LA, Caggiano JA, Herrmann HW, Knauer JP, Sayre DB, Schneider DH, Henry EA, Fortner RJ.

Rev Sci Instrum. 2015 Jul;86(7):076105. doi: 10.1063/1.4926743.

PMID:
26233419
9.

Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients.

Grant PM, Sheikh V, DerSimonian R, Rupert A, Roby G, Pau A, Sneller MC, Rico SV, Brown TT, Sereti I.

AIDS Res Hum Retroviruses. 2015 Jul;31(7):739-44. doi: 10.1089/AID.2015.0028. Epub 2015 May 21.

10.

Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults.

Grant PM, Kitch D, McComsey GA, Tierney C, Ha B, Brown TT.

HIV Clin Trials. 2015 Mar-Apr;16(2):66-71. doi: 10.1179/1528433614Z.0000000010. Epub 2015 Apr 15.

11.

Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.

Grant PM, Komarow L, Sanchez A, Sattler FR, Asmuth DM, Pollard RB, Zolopa AR.

HIV Clin Trials. 2014 Jul-Aug;15(4):133-9. doi: 10.1310/hct1504-133.

12.

Radiochemical determination of Inertial Confinement Fusion capsule compression at the National Ignition Facility.

Shaughnessy DA, Moody KJ, Gharibyan N, Grant PM, Gostic JM, Torretto PC, Wooddy PT, Bandong BB, Despotopulos JD, Cerjan CJ, Hagmann CA, Caggiano JA, Yeamans CB, Bernstein LA, Schneider DH, Henry EA, Fortner RJ.

Rev Sci Instrum. 2014 Jun;85(6):063508. doi: 10.1063/1.4883186.

PMID:
24985820
13.

Encephalitis caused by Chikungunya virus in a traveler from the Kingdom of Tonga.

Nelson J, Waggoner JJ, Sahoo MK, Grant PM, Pinsky BA.

J Clin Microbiol. 2014 Sep;52(9):3459-61. doi: 10.1128/JCM.01288-14. Epub 2014 Jun 23.

14.

Association between latent proviral characteristics and immune activation in antiretrovirus-treated human immunodeficiency virus type 1-infected adults.

Liang EC, Sceats L, Bayless NL, Strauss-Albee DM, Kubo J, Grant PM, Furman D, Desai M, Katzenstein DA, Davis MM, Zolopa AR, Blish CA.

J Virol. 2014 Aug;88(15):8629-39. doi: 10.1128/JVI.01257-14. Epub 2014 May 21.

15.
16.

Evolution of HIV treatment guidelines in high- and low-income countries: converging recommendations.

Richardson ET, Grant PM, Zolopa AR.

Antiviral Res. 2014 Mar;103:88-93. doi: 10.1016/j.antiviral.2013.12.007. Epub 2013 Dec 25. Review.

17.

Effects of a recovery-oriented cognitive therapy training program on inpatient staff attitudes and incidents of seclusion and restraint.

Chang NA, Grant PM, Luther L, Beck AT.

Community Ment Health J. 2014 May;50(4):415-21. doi: 10.1007/s10597-013-9675-6. Epub 2013 Dec 12.

PMID:
24337473
18.

Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.

Grant PM, Tierney C, Budhathoki C, Daar ES, Sax PE, Collier AC, Fischl MA, Zolopa AR, Balamane M, Katzenstein D.

HIV Clin Trials. 2013 Nov-Dec;14(6):284-91. doi: 10.1310/hct1406-284.

19.

Successfully breaking a 20-year cycle of hospitalizations with recovery-oriented cognitive therapy for schizophrenia.

Grant PM, Reisweber J, Luther L, Brinen AP, Beck AT.

Psychol Serv. 2014 May;11(2):125-33. doi: 10.1037/a0033912. Epub 2013 Sep 30.

PMID:
24079355
20.

Application of visible/near-infrared reflectance spectroscopy to uranium ore concentrates for nuclear forensic analysis and attribution.

Klunder GL, Plaue JW, Spackman PE, Grant PM, Lindvall RE, Hutcheon ID.

Appl Spectrosc. 2013 Sep;67(9):1049-56. doi: 10.1366/12-06947.

PMID:
24067636

Supplemental Content

Loading ...
Support Center